Screener
Collegium Pharmaceutical, Inc. COLL Segment — Commercial expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:CommercialExpenses.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenues, net | $199,878 | $188,000 | $393,398 | $365,757 |
| Cost of product revenues (excluding intangible asset amortization) | 26,633 | 24,143 | 47,434 | 49,103 |
| Intangible asset amortization | 62,953 | 55,473 | 118,426 | 110,946 |
| Commercial expenses | 46,403 | 44,115 | 93,760 | 84,908 |
| Corporate expenses | 12,163 | 9,801 | 26,703 | 23,090 |
| Medical expenses | 7,899 | 7,832 | 15,047 | 15,865 |
| Technical operations expenses | 165 | 136 | 415 | 234 |
| Stock-based compensation expense | 14,484 | 10,818 | 25,364 | 22,342 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s segment — commercial expenses?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — commercial expenses of $46.4M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — commercial expenses changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — commercial expenses increased by 5.2% year-over-year, from $44.12M to $46.4M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — commercial expenses?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — commercial expenses has grown at a 32.9% compound annual growth rate (CAGR), from $68.83M to $161.5M.
- What does segment — commercial expenses mean?
- Encompasses costs related to sales, marketing, and promotional activities required to drive product adoption and maintain market share. These expenditures are critical for assessing the company's investment in commercial growth and customer acquisition.
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — commercial expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude